Phosphorylated tau (p-tau) and amyloid beta (Aβ) in human plasma may provide an affordable and minimally invasive method to evaluate Alzheimer’s disease (AD) pathophysiology. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.